{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:11:42Z","timestamp":1791335502410,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2410200"],"award-info":[{"award-number":["2023YFC2410200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals\u2019 Ascent Plan","doi-asserted-by":"crossref","award":["DFL20190201"],"award-info":[{"award-number":["DFL20190201"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222025"],"award-info":[{"award-number":["7222025"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484218"],"award-info":[{"award-number":["20220484218"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13761-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:38:42Z","timestamp":1740735522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Orbital natural killer\/T-cell lymphoma: a comprehensive case series and literature review"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"1","key":"13761_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-023-01483-9","volume":"16","author":"XP Tian","year":"2023","unstructured":"Tian XP, Cao Y, Cai J, et al. Novel target and treatment agents for natural killer\/T-cell lymphoma[J]. J Hematol Oncol. 2023;16(1):78. https:\/\/doi.org\/10.1186\/s13045-023-01483-9","journal-title":"J Hematol Oncol"},{"issue":"1","key":"13761_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-022-01293-5","volume":"15","author":"E Tse","year":"2022","unstructured":"Tse E, Zhao WL, Xiong J, et al. How we treat NK\/T-cell lymphomas[J]. J Hematol Oncol. 2022;15(1):74. https:\/\/doi.org\/10.1186\/s13045-022-01293-5","journal-title":"J Hematol Oncol"},{"key":"13761_CR3","doi-asserted-by":"publisher","first-page":"103237","DOI":"10.1016\/j.critrevonc.2021.103237","volume":"159","author":"C Sanchez-Romero","year":"2021","unstructured":"Sanchez-Romero C, Bologna-Molina R, de Paes O, et al. Extranodal NK\/T cell lymphoma, nasal type: an updated overview[J]. Crit Rev Oncol Hematol. 2021;159:103237. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103237","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"13761_CR4","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1097\/HS9.0000000000000523","volume":"5","author":"JA van Doesum","year":"2021","unstructured":"van Doesum JA, Niezink AGH, Huls GA, et al. Extranodal natural Killer\/T-cell lymphoma, nasal type: diagnosis and Treatment[J]. Hemasphere. 2021;5(2):e523. https:\/\/doi.org\/10.1097\/HS9.0000000000000523","journal-title":"Hemasphere"},{"issue":"1","key":"13761_CR5","doi-asserted-by":"publisher","first-page":"e2015052","DOI":"10.4084\/MJHID.2015.052","volume":"7","author":"A Aviles","year":"2015","unstructured":"Aviles A, Nasal NK, T-Cell Lymphoma. A comparative analysis of a Mexican population with the other populations of Latin-America[J]. Mediterr J Hematol Infect Dis. 2015;7(1):e2015052. https:\/\/doi.org\/10.4084\/MJHID.2015.052","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"13761_CR6","first-page":"1677","volume":"125","author":"DAI Wei","year":"2012","unstructured":"Wei DAI, Zhong M, Wei S, et al. Natural killer T-cell lymphoma originating from the orbit[J]. Chin Med J. 2012;125(9):1677\u201380.","journal-title":"Chin Med J"},{"issue":"1","key":"13761_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12886-022-02277-2","volume":"22","author":"N Sukon","year":"2022","unstructured":"Sukon N, Tesavibul N, Choopong P, et al. Extranodal natural killer\/T-cell lymphoma presenting as hypopyon panuveitis: a case report[J]. BMC Ophthalmol. 2022;22(1):46. https:\/\/doi.org\/10.1186\/s12886-022-02277-2","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"13761_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/08820538.2016.1228405","volume":"32","author":"JC Jimenez-Perez","year":"2017","unstructured":"Jimenez-Perez JC, Yoon MK. Natural killer T-Cell lymphoma of the orbit: an Evidence-Based Approach[J]. Semin Ophthalmol. 2017;32(1):116\u201324. https:\/\/doi.org\/10.1080\/08820538.2016.1228405","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"13761_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ophtha.2005.09.036","volume":"113","author":"JJ Woog","year":"2006","unstructured":"Woog JJ, Kim YD, Yeatts RP, et al. Natural killer\/T-cell lymphoma with ocular and adnexal involvement[J]. Ophthalmology. 2006;113(1):140\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2005.09.036","journal-title":"Ophthalmology"},{"issue":"9","key":"13761_CR10","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","volume":"35","author":"H Wang","year":"2021","unstructured":"Wang H, Fu BB, Gale RP, et al. NK-\/T-cell lymphomas[J]. Leukemia. 2021;35(9):2460\u20138. https:\/\/doi.org\/10.1038\/s41375-021-01313-2","journal-title":"Leukemia"},{"issue":"8","key":"13761_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41419-024-06999-7","volume":"15","author":"W Song","year":"2024","unstructured":"Song W, Gao Y, Wu J, et al. LMP1 enhances aerobic Glycolysis in natural Killer\/T cell lymphoma[J]. Cell Death Dis. 2024;15(8):604. https:\/\/doi.org\/10.1038\/s41419-024-06999-7","journal-title":"Cell Death Dis"},{"issue":"11","key":"13761_CR12","doi-asserted-by":"publisher","first-page":"108192","DOI":"10.1016\/j.isci.2023.108192","volume":"26","author":"L He","year":"2023","unstructured":"He L, Chen N, Dai L, et al. Advances and challenges of immunotherapies in NK\/T cell lymphomas[J]. iScience. 2023;26(11):108192. https:\/\/doi.org\/10.1016\/j.isci.2023.108192","journal-title":"iScience"},{"issue":"2","key":"13761_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/bjophthalmol-2017-311704","volume":"103","author":"GI Lee","year":"2019","unstructured":"Lee GI, Kim YD, Young SM, et al. Clinical characteristics and treatment outcomes of natural killer\/T-cell lymphoma involving the ocular adnexa[J]. Br J Ophthalmol. 2019;103(2):269\u201373. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311704","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"13761_CR14","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/S0161-6420(99)90492-X","volume":"106","author":"SE Coupland","year":"1999","unstructured":"Coupland SE, Foss HD, Assaf C, et al. T-cell and T\/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases[J]. Ophthalmology. 1999;106(11):2109\u201320. https:\/\/doi.org\/10.1016\/S0161-6420(99)90492-X","journal-title":"Ophthalmology"},{"issue":"4","key":"13761_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IOP.0000000000002317","volume":"39","author":"RM Dhodapkar","year":"2023","unstructured":"Dhodapkar RM, Spadaro JZ, Heng JS, et al. NK\/T-cell lymphoma with orbital involvement: A case report and systematic review of the Literature[J]. Ophthalmic Plast Reconstr Surg. 2023;39(4):316\u201327. https:\/\/doi.org\/10.1097\/IOP.0000000000002317","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"13761_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1053\/j.seminhematol.2022.10.002","volume":"59","author":"E Tse","year":"2022","unstructured":"Tse E, Fox CP, Glover A, et al. Extranodal natural killer\/T-cell lymphoma: an overview on pathology and clinical management[J]. Seminars in hematology. WB Saunders. 2022;59(4):198\u2013209. https:\/\/doi.org\/10.1053\/j.seminhematol.2022.10.002","journal-title":"WB Saunders"},{"issue":"1","key":"13761_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/IOP.0b013e3182a7500e","volume":"30","author":"AAV Cruz","year":"2014","unstructured":"Cruz AAV, Valera FCP, Carenzi L, et al. Orbital and central nervous system extension of nasal natural Killer\/T-Cell Lymphoma[J]. Ophthalmic Plast Reconstr Surg. 2014;30(1):20\u20133. https:\/\/doi.org\/10.1097\/IOP.0b013e3182a7500e","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"13761_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/01676830.2014.902478","volume":"33","author":"K Termote","year":"2014","unstructured":"Termote K, Dierickx D, Verhoef G, et al. Series of extranodal natural Killer\/T-cell lymphoma, nasal type, with periorbital Involvement[J]. Orbit. 2014;33(4):245\u201351. https:\/\/doi.org\/10.3109\/01676830.2014.902478","journal-title":"Orbit"},{"issue":"1","key":"13761_CR19","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1038\/s41598-022-11247-z","volume":"12","author":"GN Wang","year":"2022","unstructured":"Wang GN, Zhao WG, Zhang XD, et al. A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer\/T-cell lymphoma in children and adolescents[J]. Sci Rep. 2022;12(1):7118. https:\/\/doi.org\/10.1038\/s41598-022-11247-z","journal-title":"Sci Rep"},{"issue":"5","key":"13761_CR20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.25259\/IJDVL_300_2022","volume":"89","author":"D Wang","year":"2023","unstructured":"Wang D, Min S, Lin X, et al. Clinical analysis of 20 cases of cutaneous extranodal NK\/T-Cell lymphoma[J]. Indian J Dermatol Venereol Leprol. 2023;89(5):718\u201324. https:\/\/doi.org\/10.25259\/IJDVL_300_2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"7","key":"13761_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/PAT.0000000000000161","volume":"46","author":"SS Chuang","year":"2014","unstructured":"Chuang SS. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer\/T-cell lymphomas in non-immunocompromised patients[J]. Pathology. 2014;46(7):581\u201391. https:\/\/doi.org\/10.1097\/PAT.0000000000000161","journal-title":"Pathology"},{"issue":"9","key":"13761_CR22","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1182\/bloodadvances.2023012019","volume":"8","author":"S Kato","year":"2024","unstructured":"Kato S, Hamada M, Okamoto A, et al. EBV\u2009+\u2009nodal T\/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome[J]. Blood Adv. 2024;8(9):2138\u201347. https:\/\/doi.org\/10.1182\/bloodadvances.2023012019","journal-title":"Blood Adv"},{"issue":"5","key":"13761_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/ejh.13836","volume":"109","author":"C Qiu","year":"2022","unstructured":"Qiu C, Du G. Loss of LEF-1 expression as a diagnostic indicator for extranodal NK\/T-cell lymphoma: an immunohistochemical study of 88 cases[J]. Eur J Haematol. 2022;109(5):513\u20138. https:\/\/doi.org\/10.1111\/ejh.13836","journal-title":"Eur J Haematol"},{"key":"13761_CR24","doi-asserted-by":"publisher","first-page":"105650","DOI":"10.1016\/j.humpath.2024.105650","volume":"152","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liang K, Chen H, et al. Genomic analysis reveals molecular characterization of CD30(+) and CD30(-) extranodal natural killer\/T-cell lymphomas (ENKTLs)[J]. Hum Pathol. 2024;152:105650. https:\/\/doi.org\/10.1016\/j.humpath.2024.105650","journal-title":"Hum Pathol"},{"issue":"1","key":"13761_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41598-021-02515-5","volume":"12","author":"Y Feng","year":"2022","unstructured":"Feng Y, Feng X, Jing C, et al. The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK\/T cell lymphoma[J]. Sci Rep. 2022;12(1):36. https:\/\/doi.org\/10.1038\/s41598-021-02515-5","journal-title":"Sci Rep"},{"issue":"1","key":"13761_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13000-023-01413-w","volume":"18","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Liu E, Zhang D, et al. The expression and clinical significance of PLK1\/p-PLK1 protein in NK\/T cell Lymphoma[J]. Diagn Pathol. 2023;18(1):129. https:\/\/doi.org\/10.1186\/s13000-023-01413-w","journal-title":"Diagn Pathol"},{"issue":"1","key":"13761_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/bloodadvances.2022007541","volume":"7","author":"N Oishi","year":"2023","unstructured":"Oishi N, Satou A, Miyaoka M, et al. Genetic and immunohistochemical profiling of NK\/T-cell lymphomas reveals prognostically relevant BCOR-MYC association[J]. Blood Adv. 2023;7(1):178\u201389. https:\/\/doi.org\/10.1182\/bloodadvances.2022007541","journal-title":"Blood Adv"},{"issue":"1","key":"13761_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.20892\/j.issn.2095-3941.2020.0400","volume":"18","author":"W Xue","year":"2021","unstructured":"Xue W, Zhang M. Updating targets for natural killer\/T-cell lymphoma immunotherapy[J]. Cancer Biol Med. 2021;18(1):52\u201362. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0400","journal-title":"Cancer Biol Med"},{"key":"13761_CR29","doi-asserted-by":"publisher","first-page":"1088685","DOI":"10.3389\/fimmu.2023.1088685","volume":"14","author":"Z Yan","year":"2023","unstructured":"Yan Z, Yao S, Wang Z, et al. Treatment of extranodal NK\/T-cell lymphoma: from past to future[J]. Front Immunol. 2023;14:1088685. https:\/\/doi.org\/10.3389\/fimmu.2023.1088685","journal-title":"Front Immunol"},{"key":"13761_CR30","doi-asserted-by":"publisher","unstructured":"La Rocca M, Leonardi BF, Lo Greco MC, et al. Radiotherapy of orbital and ocular adnexa lymphoma: literature review and university of Catania Experience[J]. Cancers (Basel). 2023;15(24). https:\/\/doi.org\/10.3390\/cancers15245782","DOI":"10.3390\/cancers15245782"},{"issue":"5","key":"13761_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00066-023-02165-8","volume":"200","author":"J Porte","year":"2023","unstructured":"Porte J, Hennequin C, Krizch D, et al. Extranodal nasal-type NK\/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature[J]. Strahlenther Onkol. 2023;200(5):434\u201343. https:\/\/doi.org\/10.1007\/s00066-023-02165-8","journal-title":"Strahlenther Onkol"},{"issue":"19","key":"13761_CR32","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1097\/CM9.0000000000003152","volume":"137","author":"C Wang","year":"2024","unstructured":"Wang C, Wang L. Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural Killer\/T cell lymphoma[J]. Chin Med J (Engl). 2024;137(19):2308\u201324. https:\/\/doi.org\/10.1097\/CM9.0000000000003152","journal-title":"Chin Med J (Engl)"},{"issue":"18","key":"13761_CR33","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2023021786","volume":"144","author":"L de Leval","year":"2024","unstructured":"de Leval L, Gaulard P, Dogan A. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas[J]. Blood. 2024;144(18):1855\u201372. https:\/\/doi.org\/10.1182\/blood.2023021786","journal-title":"Blood"},{"issue":"32","key":"13761_CR34","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1200\/JCO.20.01342","volume":"38","author":"CA Ramos","year":"2020","unstructured":"Ramos CA, Grover NS, Beaven AW, et al. Anti-CD30 CAR-T cell therapy in relapsed and refractory hodgkin lymphoma[J]. J Clin Oncol. 2020;38(32):3794\u2013804. https:\/\/doi.org\/10.1200\/JCO.20.01342","journal-title":"J Clin Oncol"},{"issue":"5","key":"13761_CR35","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1016\/S2352-3026(24)00066-8","volume":"11","author":"XP Tian","year":"2024","unstructured":"Tian XP, Cai J, Xia Y, et al. First-line sintilimab with Pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural Killer\/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial[J]. Lancet Haematol. 2024;11(5):e336\u201344. https:\/\/doi.org\/10.1016\/S2352-3026(24)00066-8","journal-title":"Lancet Haematol"},{"issue":"1","key":"13761_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-024-01782-8","volume":"9","author":"J Xiong","year":"2024","unstructured":"Xiong J, Cheng S, Gao X, et al. Anti-metabolic agent Pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma[J]. Signal Transduct Target Ther. 2024;9(1):62. https:\/\/doi.org\/10.1038\/s41392-024-01782-8","journal-title":"Signal Transduct Target Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13761-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13761-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13761-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:38:44Z","timestamp":1740735524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13761-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13761"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13761-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"11 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not include patients\u2019 names, portraits, or other private information. Informed consent to participate was obtained from all participants in the study. Informed consent was obtained from all subjects for the publication of this article and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"372"}}